Scholar Rock Holding (SRRK) FCF Margin (2019 - 2022)
Scholar Rock Holding (SRRK) recorded quarterly FCF Margin of 129.48% in Q1 2022, up 84.11% quarter-over-quarter from 814.94% in Q4 2021, and up 48344.0% on a YoY basis from N/an in Q1 2021.
Scholar Rock Holding (SRRK) FCF Margin (2019 - 2022) Analysis & Trends
Scholar Rock Holding's FCF Margin history runs 4 years deep, the most recent figure standing at 129.48% for Q1 2022.
- In Q1 2022, FCF Margin rose 48344.0% year-over-year to 129.48%; the TTM figure through Dec 2022 stood at 402.97% (up 29876.0% YoY), while the FY2022 annual figure was 402.97%, up 29876.0% from the prior year.
- FCF Margin was 129.48% for Q1 2022 at Scholar Rock Holding, up from 814.94% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 52.21% in Q1 2020 to a low of 830.62% in Q3 2020.
- Historically, FCF Margin has averaged 483.41% across 4 years, with a median of 515.55% in 2019.
- The sharpest annual moves came in 2020 and 2021: FCF Margin jumped 56776 bps in 2020, then plunged 66512 bps in 2021.
- A 4-year view of FCF Margin shows it stood at 231.57% in 2019, then sank by 172 bps to 630.36% in 2020, then fell by 29 bps to 814.94% in 2021, then surged by 84 bps to 129.48% in 2022.
- The last three FCF Margin figures came in at 129.48% (Q1 2022), 814.94% (Q4 2021), and 732.94% (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -129.48% |
| Dec 31, 2021 | -814.94% |
| Sep 30, 2021 | -732.94% |
| Jun 30, 2021 | -655.84% |
| Mar 31, 2021 | -612.91% |
| Dec 31, 2020 | -630.36% |
| Sep 30, 2020 | -830.62% |
| Jun 30, 2020 | -515.38% |
| Mar 31, 2020 | 52.21% |
| Dec 31, 2019 | -231.57% |
| Sep 30, 2019 | -350.44% |
| Jun 30, 2019 | -316.53% |
| Mar 31, 2019 | -515.55% |